Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ensign GroupENSG 91 EV-to-EBIT is 24.81 as of Aug. 20, 2026, which is 4% above its 10-year median of 23.88. GuruFocus rates ENSG with a GF Score™ of 91/100 and a GF Value™ of $183.09 (Fairly Valued). The stock has 3 warning signs investors should review. Among 475 Healthcare Providers & Services companies, Ensign Group ranks worse than 71.16% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Ensign Group's Enterprise Value for the quarter that ended in Jun. 2026 was $11,274 Mil.
Ensign Group's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $507 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ensign Group EV-to-EBIT Related Terms
Ensign Group EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Ensign Group's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ensign Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ensign Group EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ensign Group's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Ensign Group's EV-to-EBIT falls into.
Ensign Group's current Enterprise Value is $12,571 Mil.
Ensign Group's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $507 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ensign Group (ENSG) has a EV-to-EBIT of 24.81 as of Aug. 20, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ensign Group and its competitors. This is near median its historical median of 23.88. Over the past decade, Ensign Group's EV-to-EBIT has ranged from 11.47 to 54.49. According to the industry distribution chart, Ensign Group ranks #338 out of 475 companies in the Healthcare Providers & Services industry, placing it in the top 71.2%.
Is Ensign Group's EV-to-EBIT too high?
Ensign Group's current EV-to-EBIT of 24.81 is near median its 10-year median of 23.88. Over the past 10 years, this metric has ranged from a low of 11.47 to a high of 54.49. The Healthcare Providers & Services industry median EV-to-EBIT is 15.89. Ensign Group's value of 24.81 is 56.1% above this industry median. Based on the distribution chart, Ensign Group ranks #338 out of 475 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ensign Group has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ensign Group's EV-to-EBIT compare to UHS and EHC?
According to the Healthcare Providers & Services industry distribution chart, Ensign Group ranks #338 out of 475 companies for EV-to-EBIT. This places Ensign Group in the lower half of its industry. The industry median EV-to-EBIT is 15.89. Ensign Group's value of 24.81 is 56.1% above this benchmark. Historically, Ensign Group's own EV-to-EBIT has ranged from 11.47 to 54.49 over the past decade. While the company's 10-year median is 23.88 vs. the industry median of 15.89, Ensign Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.89, based on 475 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ensign Group's current EV-to-EBIT of 24.81 is 56.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ensign Group and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ensign Group's current EV-to-EBIT is 24.81, which is near median its own 10-year median of 23.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ensign Group stock overvalued right now?
Based on GuruFocus' analysis, Ensign Group (ENSG) is currently considered Fairly Valued. The stock's GF Value™ is $183.09, compared to a current price of $182.53 — trading 0.3% below its estimated fair value. The current EV-to-EBIT is 24.81, which is near median its 10-year median of 23.88 and 56.1% above the Healthcare Providers & Services industry median of 15.89. Ensign Group's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Ensign Group (ENSG), the current EV-to-EBIT is 24.81 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ensign Group (ENSG) Overvalued in 2026?
Based on GuruFocus' analysis, Ensign Group stock appears to be undervalued.
The current stock price of $182.53 is trading 0.3% below its estimated GF Value™ of $183.09.
GuruFocus considers Ensign Group to be Fairly Valued.
Key valuation signals for ENSG:
EV-to-EBIT: 24.81 (near median its 10-year median of 23.88)
GF Value™: $183.09 vs. price of $182.53 (0.3% below fair value)
Industry Position: 56.1% above the Healthcare Providers & Services median (#338 of 475)
No single metric tells the full story. See the ENSG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
91GF Score
Get the complete analysis for ENSG
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ENSG has been successfully added to your 
